U.S. market Closed. Opens in 17 hours 8 minutes

IDYA | IDEAYA Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue23.39M50.93M27.94M19.54MN/AN/AN/A
Cost of Revenue4.01M2.10M1.73M39.70M1.25MN/AN/A
Gross Profit19.38M48.83M26.22M-20.16M-1.25MN/AN/A
Operating Expenses157.81M113.43M78.21M54.88M44.27M36.42M14.44M
Selling, General & Admin28.31M23.90M20.05M15.18M9.95M4.67M2.05M
Research & Development129.51M89.54M58.16M39.70M34.32M31.75M12.38M
Other Operating ExpensesN/AN/AN/AN/A8.00K77.00KN/A
Operating Income-134.43M-62.50M-50.27M-35.34M-44.27M-36.42M-14.44M
Other Expenses / Income21.47M3.85M506.00K849.00K2.30M77.00K2.58M
Before Tax Income-112.96M-58.66M-49.76M-34.49M-41.98M-34.35M-11.86M
Income Tax Expenses3.84M-3.85M-2.23M-2.23M-3.53M2.07MN/A
Net Income-112.96M-54.81M-47.53M-32.27M-38.44M-34.35M-11.86M
Interest Expenses21.47M3.85MN/A849.00KN/AN/AN/A
Basic Shares Outstanding57.52M41.44M35.25M24.72M20.23M14.24M14.24M
Diluted Shares Outstanding57.52M41.44M35.25M24.72M20.23M14.24M14.24M
EBITDA-130.42M-62.50M-50.27M-35.34M-44.27M-35.53M-11.47M
EBITDA Margin-557.71%-122.72%-179.91%-180.90%0.00%0.00%0.00%
EBIT-87.65M-54.81M-49.76M-33.65M-41.98M-32.27M-11.86M
EBIT Margin-374.83%-107.61%-178.10%-172.21%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙